Skip to content
Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma
Small Cell Lung Cancer: 1L and Beyond
Survivorship in the Modern Era of Cancer Care: Goals, Measures, and Outcomes
T-Cell NHL: Novel Approaches & Challenges
The Art-of-Medicine in Treating Chronic Lymphocytic Leukemia
Thrombophilia & Thrombosis in Cancer Patients: Novel Advances
Thymoma and Thymic Carcinomas
Toxicities in Immunotherapy
Waldenstrom’s Macroglobulinemia
Walking Alongside Patients in Cancer
Sequencing Endocrine Therapy and Targeted Agents for the Treatment of Metastatic HR+/HER2- Breast Cancer
Optimal Treatment for Early Stage HER2 Positive Breast Cancer: Tailoring Treatment to Response
Management of Osteonecrosis of Jaw and Other Complications from Bisphosphonate and/or RANK Ligand Inhibitors
Management of Neurological Toxicities from Immunotherapy: Diagnosis, Assessement and Therapy
Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates
Novel Treatment for Unresectable Stage III NSCLC
Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials
Novel Trial Designs for Early Phase Clinical Trials: Beyond 3+3
Translating Pre-Clinical Studies to NCI-CTEP Clinical Trials
Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC
Advances in Non-PD(L)1 Immunotherapies
Advances in Car-T Cells Development for Cancer Therapy
Management of Immune Related Adverse Events
Pancreatic and Hepatobiliary Cancer: Emerging Strategies
Post navigation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
